Banister et al. (2014) study
Study / Research
A 2014 epidemiological study that suggested type 2 diabetics taking Metformin lived slightly longer than non-diabetics without diabetes, raising interest in Metformin as a geroprotective compound; later found to have methodological flaws.
Mentioned in 2 videos
Videos Mentioning Banister et al. (2014) study
Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects
Andrew Huberman
An influential 2014 paper that suggested a survival advantage in type 2 diabetics treated with Metformin, which generated significant excitement for its geroprotective potential. Later re-evaluated due to methodological limitations.
300-Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, & more
Peter Attia MD
A 2014 epidemiological study that suggested type 2 diabetics taking Metformin lived slightly longer than non-diabetics without diabetes, raising interest in Metformin as a geroprotective compound; later found to have methodological flaws.